Table 1. Medico-Demographic Characteristics of 1,160 Cancer Survivors During Re-entrya, by Level of Physical Activity, National Cancer Survivor Transition Study, 2013b .
| Characteristic | Total | Inactivec | Insufficient Activityd | Within Guidelinese | Exceeds Guidelinesf | P Valueg |
|---|---|---|---|---|---|---|
| Overall | 1,160 (100) | 94 (8.1) | 396 (34.1) | 282 (24.3) | 388 (33.4) | NA |
| Sex | ||||||
| Male | 493 (42.5) | 30 (6.1) | 181 (36.7) | 107 (21.7) | 175 (35.5) | .02 |
| Female | 667 (57.5) | 64 (9.6) | 215 (32.2) | 175 (26.2) | 213 (31.9) | |
| Race/ethnicity | ||||||
| Non-Hispanic white | 974 (84.5) | 71 (7.3) | 341 (35.0) | 243 (25.0) | 319 (32.8) | .06 |
| Other | 179 (15.5) | 22 (12.3) | 54 (30.2) | 37 (20.7) | 66 (36.9) | |
| Education | ||||||
| High school graduate or less | 411 (35.6) | 43 (10.5) | 172 (41.9) | 88 (21.4) | 108 (26.3) | <.001 |
| Some college or more | 743 (64.4) | 51 (6.9) | 221 (29.7) | 191 (25.7) | 280 (37.7) | |
| Marital status | ||||||
| Married | 794 (68.9) | 55 (6.9) | 263 (33.1) | 189 (23.8) | 287 (36.2) | .02 |
| Not marriedh | 359 (31.1) | 39 (10.9) | 129 (35.9) | 90 (25.1) | 101 (28.1) | |
| Smoking status | ||||||
| Nonsmoker | 540 (50.4) | 35 (6.5) | 176 (32.6) | 128 (23.7) | 201 (37.2) | .19 |
| Former smoker | 428 (40.0) | 37 (8.6) | 145 (33.9) | 110 (25.7) | 136 (31.8) | |
| Current smoker | 103 (9.6) | 12 (11.7) | 40 (38.8) | 23 (22.3) | 28 (27.2) | |
| Cancer type | ||||||
| Breast | 396 (34.1) | 33 (8.3) | 136 (34.3) | 99 (25.0) | 128 (32.3) | .26 |
| Colorectal | 423 (36.3) | 41 (9.7) | 129 (30.5) | 105 (24.8) | 148 (35.0) | |
| Prostate | 341 (29.6) | 20 (5.9) | 131 (38.4) | 78 (22.9) | 112 (32.8) | |
| Cancer stage | ||||||
| Local | 706 (62.4) | 56 (7.9) | 251 (35.6) | 173 (24.5) | 226 (32.0) | .38 |
| Regional or distant | 426 (37.6) | 33 (7.8) | 135 (31.7) | 101 (23.7) | 157 (36.9) | |
| Surgery | ||||||
| Yes | 941 (81.3) | 78 (8.3) | 305 (32.4) | 235 (25.0) | 323 (34.3) | .09 |
| No | 217 (18.7) | 16 (7.4) | 90 (41.5) | 46 (21.2) | 65 (30.0) | |
| Chemotherapy | ||||||
| Yes | 716 (62.2) | 66 (9.3) | 233 (32.5) | 174 (24.3) | 243 (33.9) | .22 |
| No | 435 (37.8) | 27 (6.2) | 159 (36.6) | 107 (24.6) | 142 (32.6) | |
| Continuous variables, mean (SD) | ||||||
| Age, y | 62.2 (10.9) | 62.8 (11.7) | 63.5 (10.6) | 63.0 (10.5) | 60.1 (11.1) | <.001 |
| Body mass index | 29.0 (6.5) | 30.3 (6.4) | 30.4 (7.1) | 28.1 (5.7) | 28.0 (6.0) | <.001 |
| No. of comorbidities | 1.9 (1.6) | 2.5 (1.7) | 2.1 (1.6) | 1.9 (1.6) | 1.5 (1.5) | <.001 |
| Time since treatment, months | 7.8 (3.3) | 7.4 (3.6) | 7.7 (3.2) | 7.9 (3.4) | 7.9 (3.2) | .48 |
Abbreviation: MET, metabolic equivalent of task; NA, not applicable; SD, standard deviation.
The transition from active cancer treatment into survivorship.
All values are n (%) except where otherwise noted. All percentages presented above are valid percentages and do not include missing data. Percentages for missing data are as follows: age, 0.1%; sex, 0.0%; race/ethnicity, 0.6%; education, 0.5%; marital status, 0.6%; smoking status, 7.7%; cancer type, 0.0%; cancer stage, 2.4%; time since treatment, 0.0%; surgery, 0.2%; chemotherapy, 0.8%; body mass index, 10.0%; and number of comorbidities, 0.9%.
0 MET h/wk.
0.01–8.74 MET h/wk.
8.75–17.49 MET h/wk.
17.50 or more MET h/wk.
P value is from the omnibus test of association from simple multinomial regression models.
Not married includes people who are single, separated, divorced, or widowed.